• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Frequency of Extended-Spectrum β-Lactamase Genes Harbored by Enterobacterales Isolates at High Risk for Clinically Significant Chromosomal Expression.

作者信息

Hareza Dariusz, Simner Patricia J, Bergman Yehudit, Jacobs Emily, Cosgrove Sara E, Tamma Pranita D

机构信息

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Open Forum Infect Dis. 2023 Mar 29;10(4):ofad175. doi: 10.1093/ofid/ofad175. eCollection 2023 Apr.

DOI:10.1093/ofid/ofad175
PMID:37065982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10096897/
Abstract
摘要

相似文献

1
The Frequency of Extended-Spectrum β-Lactamase Genes Harbored by Enterobacterales Isolates at High Risk for Clinically Significant Chromosomal Expression.具有临床显著染色体表达高风险的肠杆菌目分离株携带的超广谱β-内酰胺酶基因频率
Open Forum Infect Dis. 2023 Mar 29;10(4):ofad175. doi: 10.1093/ofid/ofad175. eCollection 2023 Apr.
2
Characterization of beta-lactamase producing isolated from an urban community wastewater treatment plant in Iran.从伊朗一个城市社区污水处理厂分离出的产β-内酰胺酶菌株的特性分析。
Iran J Microbiol. 2023 Aug;15(4):521-532. doi: 10.18502/ijm.v15i4.13506.
3
Fecal Carriage of Extended-Spectrum β-Lactamases and pAmpC Producing in an Iranian Community: Prevalence, Risk Factors, Molecular Epidemiology, and Antibiotic Resistance.伊朗社区中产超广谱β-内酰胺酶和 pAmpC 型肠杆菌科细菌的粪便携带情况：流行率、危险因素、分子流行病学和抗生素耐药性。
Microb Drug Resist. 2022 Sep;28(9):921-934. doi: 10.1089/mdr.2021.0029. Epub 2022 Sep 5.
4
Prevalence of Extended-Spectrum and Metallo β-Lactamase Production in AmpC β-Lactamase Producing Pseudomonas aeruginosa Isolates From Burns.烧伤患者分离出的产AmpCβ-内酰胺酶铜绿假单胞菌中产超广谱β-内酰胺酶和金属β-内酰胺酶的发生率
Jundishapur J Microbiol. 2014 Sep;7(9):e16436. doi: 10.5812/jjm.16436. Epub 2014 Sep 23.
5
In vitro susceptibilities of isolates of potentially naturally inducible chromosomal AmpC-producing metallo-β-lactamase-negative carbapenem-resistant Enterobacterales species to ceftazidime-avibactam: Data from the Antimicrobial Testing Leadership and Surveillance Programme, 2012-2019.2012-2019 年抗菌药物测试领导和监测项目中，潜在天然诱导染色体 AmpC 型金属β-内酰胺酶阴性碳青霉烯类耐药肠杆菌科种分离株对头孢他啶-阿维巴坦的体外药敏试验结果。
Int J Antimicrob Agents. 2022 Sep;60(3):106617. doi: 10.1016/j.ijantimicag.2022.106617. Epub 2022 Jun 17.
6
Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial.美罗培南优化研究（MERINO）中头孢替坦对产 ESBL 大肠埃希菌和肺炎克雷伯菌血流分离株的活性。
Microbiol Spectr. 2021 Sep 3;9(1):e0022621. doi: 10.1128/Spectrum.00226-21. Epub 2021 Jul 7.
7
Characterization of Extended Spectrum Cephalosporin-Resistant Strains Isolated from Raw Poultry Carcasses in Catering Services in Northern Greece.从希腊北部餐饮服务中生鲜家禽胴体分离出的超广谱头孢菌素耐药菌株的特性分析
Vet Sci. 2023 Jul 27;10(8):487. doi: 10.3390/vetsci10080487.
8
Rapid Detection of Extended-Spectrum β-Lactamases (ESBL) and AmpC β-Lactamases in : Development of a Screening Panel Using the MALDI-TOF MS-Based Direct-on-Target Microdroplet Growth Assay.快速检测超广谱β-内酰胺酶（ESBL）和AmpCβ-内酰胺酶：基于基质辅助激光解吸电离飞行时间质谱（MALDI-TOF MS）的直接靶点微滴生长分析法筛选面板的开发
Front Microbiol. 2019 Jan 24;10:13. doi: 10.3389/fmicb.2019.00013. eCollection 2019.
9
Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States.美国一家学术医疗中心中对头孢曲松不敏感的肠杆菌科分离株的分子流行病学
Open Forum Infect Dis. 2019 Aug 11;6(8):ofz353. doi: 10.1093/ofid/ofz353.
10
Distribution of β-lactamases and emergence of carbapenemases co-occurring Enterobacterales isolates with high-level antibiotic resistance identified from patients with intra-abdominal infection in the Asia-Pacific region, 2015-2018.2015 - 2018年亚太地区腹腔内感染患者中同时存在β-内酰胺酶分布及碳青霉烯酶产生的具有高水平抗生素耐药性的肠杆菌科分离株情况
J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 2):1263-1272. doi: 10.1016/j.jmii.2021.07.007. Epub 2021 Jul 21.

引用本文的文献

1
Cefepime Versus Carbapenem Therapy for the Treatment of Invasive Infections With Inducible Chromosomal AmpC-Producing Enterobacterales: A Systematic Review and Meta-analysis.头孢吡肟与碳青霉烯类疗法治疗产诱导型染色体AmpC肠杆菌科细菌引起的侵袭性感染：一项系统评价和荟萃分析。
Open Forum Infect Dis. 2025 Jul 14;12(7):ofaf413. doi: 10.1093/ofid/ofaf413. eCollection 2025 Jul.
2
Cefepime versus carbapenem for treating complicated urinary tract infection caused by cefoxitin-nonsusceptible ESCPM organisms: a multicenter, real-world study.头孢吡肟与碳青霉烯类药物治疗由头孢西丁不敏感的肠杆菌科细菌、葡萄球菌和假单胞菌（ESCPM）引起的复杂性尿路感染：一项多中心、真实世界研究
BMC Infect Dis. 2025 Mar 31;25(1):439. doi: 10.1186/s12879-025-10850-5.
3
Piperacillin/tazobactam vs. cefepime or carbapenems for the treatment of bloodstream infections due to bacteria producing chromosomal AmpC beta-lactamase: a systematic review and meta-analysis.哌拉西林/他唑巴坦与头孢吡肟或碳青霉烯类药物治疗产染色体AmpCβ-内酰胺酶细菌所致血流感染的系统评价和荟萃分析
Infection. 2024 Dec 4. doi: 10.1007/s15010-024-02447-y.
4
Antibiotic Treatment of Infections Caused by AmpC-Producing Enterobacterales.产AmpC肠杆菌科细菌所致感染的抗生素治疗
Pharmacy (Basel). 2024 Sep 21;12(5):142. doi: 10.3390/pharmacy12050142.

本文引用的文献

1
Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy.危重病早期头孢吡肟浓度是否足够：精准药物治疗的一个案例。
Pharmacotherapy. 2023 Nov;43(11):1112-1120. doi: 10.1002/phar.2766. Epub 2023 Feb 2.
2
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections.美国传染病学会关于治疗产 AmpC β-内酰胺酶肠杆菌科、耐碳青霉烯类鲍曼不动杆菌和嗜麦芽窄食单胞菌感染的指南。
Clin Infect Dis. 2022 Jul 6;74(12):2089-2114. doi: 10.1093/cid/ciab1013.
3
Administration of a β-Lactam Prior to Vancomycin as the First Dose of Antibiotic Therapy Improves Survival in Patients With Bloodstream Infections.β-内酰胺类抗生素在万古霉素之前给药作为抗生素治疗的首剂可改善血流感染患者的生存。
Clin Infect Dis. 2022 Aug 24;75(1):98-104. doi: 10.1093/cid/ciab865.
4
Modifiable Risk Factors for the Emergence of Ceftolozane-tazobactam Resistance.可改变的头孢洛扎他唑巴坦耐药出现的危险因素。
Clin Infect Dis. 2021 Dec 6;73(11):e4599-e4606. doi: 10.1093/cid/ciaa1306.
5
Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems.碳青霉烯类与非碳青霉烯类治疗产 AmpC 肠杆菌科血流感染的结局比较。
Int J Antimicrob Agents. 2020 Feb;55(2):105860. doi: 10.1016/j.ijantimicag.2019.105860. Epub 2019 Dec 11.
6
Clinical Impact of Revised Cefepime Breakpoint in Patients With Bacteremia.修订后的头孢吡肟折点对菌血症患者的临床影响
Open Forum Infect Dis. 2019 Jul 28;6(8):ofz341. doi: 10.1093/ofid/ofz341. eCollection 2019 Aug.
7
Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States.美国一家学术医疗中心中对头孢曲松不敏感的肠杆菌科分离株的分子流行病学
Open Forum Infect Dis. 2019 Aug 11;6(8):ofz353. doi: 10.1093/ofid/ofz353.
8
Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase.肠杆菌科染色体编码诱导型 AmpCβ-内酰胺酶的ampC 去阻遏的种属特异性突变率。
J Antimicrob Chemother. 2018 Jun 1;73(6):1530-1536. doi: 10.1093/jac/dky084.
9
Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.哌拉西林-他唑巴坦、头孢吡肟和厄他培南治疗产超广谱β-内酰胺酶大肠埃希菌所致尿路感染的随机对照试验
BMC Infect Dis. 2017 Jun 7;17(1):404. doi: 10.1186/s12879-017-2502-x.
10
The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections.非碳青霉烯类β-内酰胺类药物在治疗产超广谱β-内酰胺酶感染中的应用
Clin Infect Dis. 2017 Apr 1;64(7):972-980. doi: 10.1093/cid/cix034.